Hemoperfusion Market Analysis - Global Industry Size, Share, Trends and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Forthcoming | Report ID : ARC559

Introduction

Hemoperfusion is a treatment technique that uses an adsorbent substance such as charcoal or resins to help remove toxic substances from blood in large volumes. The hemoperfusion system is prepared by the process of sterilization of cartridge containing the adsorbent, and rinsing it with heparinized saline solution. The market for hemoperfusion has witnessed significant growth due to rising demand from various applications such as treatment of liver (hepatic) failure and autoimmune diseases.

Market Dynamics

The increasing use of adsorbent substance technique to remove toxic substances and poisons, investment in emerging economies (such as, India, China, Brazil, South East-Asia and Mexico) and high growth in end use industries is driving the market for hemoperfusion, globally. Increased use of hemoperfusion in healthcare such as providing supportive treatment before and after transplantation for patients in case of liver failure, and emergence of new end users of hemoperfusion is expected to change the dynamics of the market in near future. Some of the key challenges include risk such as infection, blood clotting, destruction of blood platelets, and organ failure associated with hemoperfusion restrict the adoption of this technology to larger extent.

Market Classification and Overview

The hemoperfusion market is bifurcated on the basis of type, application, end-use industry, and geography. The different types of hemoperfusion include charcoal, certain resins and polymer. Charcoal hemoperfusion is the largest market segment and is most widely used type as it caters to majority of applications. It is more popularly used type of hemoperfusion as it is efficient to treat liver (hepatic) failure, poisoning, autoimmune diseases when coated with antigens/ antibodies, and have greater affinity for water-soluble molecules. However, certain resin hemoperfusion is the fastest growing type in hemoperfusion market. This is mainly because they are more efficient than charcoal hemoperfusion in clearing lipid-soluble drugs from patient’s blood. Polymer based hemoperfusion technique has been undergoing clinical tests in the United States since 2002. Based on application, the market is further segmented into specific intoxication, hepatic encephalopathy, certain autoimmune diseases, overdose and others. Hepatic encephalopathy accounts for the major value of the global consumption of hemoperfusion market and led the global hemoperfusion demand followed by specific intoxication and certain autoimmune diseases segments. Its growth is driven by increasing demand from end-use industries. Though hemoperfusion technique is highly available, it is majorly used as a medical process to remove toxic substances from a patient’s blood.

Regional Overview

The market for hemoperfusion is segmented into regions such as North America, Europe, Asia-Pacific, Latin America, and Middle-East and Africa (MEA). North America was the major contributors to the growth of hemoperfusion market in 2015. Asia-Pacific was the second biggest market followed by Europe. The market for hemoperfusion in Asia-Pacific is further projected to witness highest growth in coming years owing to the rapid growth of healthcare and pharmaceutical industry as well as increase in health awareness among middle class population in the region. The North American market for hemoperfusion is likely to grow at a significant rate owing to the increase in demand from healthcare sector.

Report Coverage

Market

Hemoperfusion Market

Analysis Period

2015 – 2026

Historic Data

2015 – 2016

Base Year

2017

Forecast Data

2018 – 2026

Market Stratification

Type, Application, End-Use Industry, Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis,

Player Profiling, Value Chain Analysis

Market Participants

Baxter International Inc. (Gambro), Asahi Kasei Corporation, Kaneka Corporation, Toray Medical Co. Ltd., Fresenius SE & Co. KGaA, B. Braun Melsungen AG, Abbott Laboratories, Johnson & Johnson and Jafron Biomedical Co., Ltd. are the key players in the hemoperfusion market.

Market Segmentation

Market By Type

·         Charcoal Hemoperfusion

·         Certain Resins Hemoperfusion

·         Polymer Hemoperfusion

Market By Application

·         Specific Intoxication

·         Hepatic Encephalopathy

·         Certain Autoimmune Diseases

·         Overdose

·         Others

Market By End-Use Industry

·         Pharmaceuticals

·         Healthcare

·         Others

Market By Geography

·         North America

o   US

o   Canada

o   Mexico

·         Europe

o   UK

o   Germany

o   France

o   Rest of Europe

·         Asia-Pacific

o   China

o   Japan

o   India

o   Australia

o   Rest of Asia-Pacific

·         Latin America

o   Brazil

o   Rest of Latin America

·         Middle East and Africa (MEA)

o   South Africa

o   Saudi Arabia

o   Rest of MEA


Related Reports

Meningococcal Vaccines Market (By Type: Combination Vaccines [MenHibrix, Menitorix], Conjugate Vaccines [Menactra, MenAfriVac, Meningitec, Menjugate, Menveo, NeisVac-C, Nimenrix, NmVac4-DT], Polysaccharide [Mencevax, Menomune, NmVac4, Others], Men B Vaccines [Bexsero, Trumenba], Others; By End User: Retail Pharmacies, Hospital Pharmacies, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction: Meningococcal vaccines are utilized to treat meningitis brought about by bacterium N. meningitidis. Beforehand there were no careful steps accessible to maintain a strategic distance from meningitis. Anti-infection agents alongside supplement supplements were utilized to treat this ailment after the disease was affirmed. In any case, with the approach of the meningoco

Real-time PCR (qPCR) and Digital PCR (dPCR) Market (By Technology: Digital, Quantitative; By Product: Instruments, Reagents and Consumables, Software & Services; By Application: Research [Forensic and Others], Clinical [Pathogen Testing, Oncology Testing, Blood Screening, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Real-time PCR (qPCR) & Digital PCR (dPCR) market is expected to grow at noteworthy CAGR around 8.1 % throughout the forecast period and reach around US$ 4.2 billion by 2026. In order to amplify or make more copies of the deoxyribonucleic acid (DNA) sequence

Nebulizer Market (By Type: Mesh, Pneumatic [Portable, Standalone], Ultrasonic [Portable, Standalone) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Nebulizer market is expected to grow at noteworthy CAGR around 6.2 % throughout the forecast period and reach around US$ 1.4 billion by 2026. Nebulizer is a medical device that converts the medicine into a nebula and directly into the pulmonary system. Nebuliza

Motion Preservation Devices Market (By Product: Total Disc Replacement Devices, Prosthetic Nucleus Replacement Devices, Posterior Dynamic Devices, Facet Replacement Devices; By Surgery: Open Spine Surgery, Minimally Invasive Spine Surgery; By End Use: Hospitals, Ambulatory Surgical Centers, Orthopedic Centers and Clinics) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Motion Preservation Devices market is expected to grow at noteworthy CAGR around 10.5 % throughout the forecast period and reach around US$ 1.5 billion by 2026. In spinal disorders, movement preservation devices are used. Motion conservation devices are used to

Hemoglobinopathy Market (By Type: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Therapy: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb Variants Diseases; By Diagnosis: Thalassemia [Beta Thalassemia, Alpha Thalassemia], Sickle Cell Disease, Other Hb variants diseases) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Introduction According to Acumen Research and Consulting, the global Hemoglobinopathy market is expected to grow at noteworthy CAGR around 10 % throughout the forecast period and reach around US$ 12 billion by 2026. Hemoglobinopathy is a genetic disorder that causes structural abnormalities in hemoglobin molecules. Hemoglobinopa

Cart Summary